argenx SE (EBR: ARGX)
Belgium
· Delayed Price · Currency is EUR
628.40
-6.00 (-0.95%)
Jan 21, 2025, 4:52 PM CET
argenx SE Employees
argenx SE had 1,148 employees as of December 31, 2023. The number of employees increased by 305 or 36.18% compared to the previous year.
Employees
1,148
Change (1Y)
305
Growth (1Y)
36.18%
Revenue / Employee
€1,490,683
Profits / Employee
€31,469
Market Cap
37.81B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UCB SA | 9,083 |
Fagron NV | 3,282 |
Nyxoah | 147 |
Ion Beam Applications | 2,145 |
Onward Medical | 99 |
Hyloris Pharmaceuticals | 41 |
Sequana Medical NV | 62 |
Celyad Oncology | 19 |
argenx SE News
- 4 days ago - Argenx cut to Sell at Deutsche Bank on valuation - Seeking Alpha
- 8 days ago - Immunology company argenx estimates higher product net sales from last year - Seeking Alpha
- 8 days ago - argenx SE (ARGX) Announces Preliminary 2024 Financial Results and Strategic Priorities for 2025 - GuruFocus
- 8 days ago - argenx Highlights 2025 Strategic Priorities - GlobeNewsWire
- 15 days ago - argenx to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 18 days ago - Here's How Much You Would Have Made Owning argenx Stock In The Last 5 Years - Benzinga
- 25 days ago - argenx SE (ARGX) Gains Approval for VYVDURA in Japan for CIDP Treatment - GuruFocus
- 25 days ago - argenx Announces Approval of VYVDURA (efgartigimod alfa and hyaluronidase-qvfc) in Japan for Adults with Chronic Inflammatory Demyelinating Polyneuropathy - GlobeNewsWire